Market Research Logo

SMS Pharmaceuticals Ltd (SMSPHARMA) - Financial and Strategic SWOT Analysis Review

SMS Pharmaceuticals Ltd (SMSPHARMA) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

SMS Pharmaceuticals Ltd (SMS Pharma) is a manufacturer of active pharmaceutical ingredients (APIs) and intermediates that develops offers anti-fungal, anti-ulcer, anti-migraine, anti-hypersensitive, anti-psychotic, anti-viral and other products. Its pipeline products include Ticagrelor, Clopidogrel Bisulfate, Montelukast Sodium, Apixaban, Rivaroxaban, Gabapentin Enacarbil, Lamotrigine and Sofosbuvir among others. Its contract research includes study of synthetic feasibility, process development and scale up, selection of synthetic route and lead optimization and analogue synthesis. It has four manufacturing facilities namely Khazipally unit, Bachupally unit, Jeedimetla unit and Visakhapatnam unit. SMS Pharma is headquartered in Hyderabad, Telangana, India.
SMS Pharmaceuticals Ltd Key Recent Developments

Jun 15,2018: SMS Pharmaceuticals Announces Board Change
May 30,2018: SMS Pharmaceuticals Appoints Mr. Shravan Kudaravalli As Additional Director
Jan 22,2018: SMS Pharmaceuticals Receives Establishment Inspection Report from US FDA
Nov 18,2017: SMS Pharmaceuticals has successfully completed, its Fifth US Food and Drug Administration (US FDA) inspection
Aug 23,2017: SMS Pharmaceuticals updates on Pharmaceuticals and Medical Devices Agency inspection at manufacturing facility Unit4I, located at Bachupally

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
SMS Pharmaceuticals Ltd - Key Facts
SMS Pharmaceuticals Ltd - Key Employees
SMS Pharmaceuticals Ltd - Key Employee Biographies
SMS Pharmaceuticals Ltd - Major Products and Services
SMS Pharmaceuticals Ltd - History
SMS Pharmaceuticals Ltd - Company Statement
SMS Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
SMS Pharmaceuticals Ltd - Business Description
SMS Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
SMS Pharmaceuticals Ltd - Strengths
SMS Pharmaceuticals Ltd - Weaknesses
SMS Pharmaceuticals Ltd - Opportunities
SMS Pharmaceuticals Ltd - Threats
SMS Pharmaceuticals Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
SMS Pharmaceuticals Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 18, 2017: SMS Pharmaceuticals has successfully completed, its Fifth US Food and Drug Administration (US FDA) inspection
Aug 23, 2017: SMS Pharmaceuticals updates on Pharmaceuticals and Medical Devices Agency inspection at manufacturing facility Unit4I, located at Bachupally
May 30, 2017: SMS Pharmaceuticals Announces Resignation of Mr. N. Rajendra Prasad as Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
SMS Pharmaceuticals Ltd, Key Facts
SMS Pharmaceuticals Ltd, Key Employees
SMS Pharmaceuticals Ltd, Key Employee Biographies
SMS Pharmaceuticals Ltd, Major Products and Services
SMS Pharmaceuticals Ltd, History
SMS Pharmaceuticals Ltd, Other Locations
SMS Pharmaceuticals Ltd, Key Competitors
SMS Pharmaceuticals Ltd, Ratios based on current share price
SMS Pharmaceuticals Ltd, Annual Ratios
SMS Pharmaceuticals Ltd, Annual Ratios (Cont...1)
SMS Pharmaceuticals Ltd, Annual Ratios (Cont...2)
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
SMS Pharmaceuticals Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
SMS Pharmaceuticals Ltd, Performance Chart (2014 - 2018)
SMS Pharmaceuticals Ltd, Ratio Charts
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report